Our results suggest that BET inhibitors (such as JQ1) which are currently in active clinical trials for cancer treatments with nM range of EC5044 have potential application in PCN detoxification, thereby supporting anti-PA infection treatment45. This evidence concerns the gene DNER and cancer.